Evidence map›Paper›PMID 40132543›Full record

ArticleCell reports methods2025

Rapid and robust generation of cardiomyocyte-specific crispants in zebrafish using the cardiodeleter system.

Sean Keeley, Miriam Fernández-Lajarín, David Bergemann, Nicolette John, Lily Parrott, Brittany E Andrea, Juan Manuel González-Rosa

Abstract read
In one paragraph

Article in Cell reports methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Sean KeeleyBiology Department, Morrissey College of Arts and Sciences, Boston College, Chestnut Hill, MA 02467, USA; Cardiovascular Research Center, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA 02129, USA.
Miriam Fernández-LajarínBiology Department, Morrissey College of Arts and Sciences, Boston College, Chestnut Hill, MA 02467, USA; Cardiovascular Research Center, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA 02129, USA.
David BergemannCardiovascular Research Center, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA 02129, USA.
Nicolette JohnCardiovascular Research Center, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA 02129, USA.
Lily ParrottBiology Department, Morrissey College of Arts and Sciences, Boston College, Chestnut Hill, MA 02467, USA.
Brittany E AndreaCardiovascular Research Center, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA 02129, USA.
Juan Manuel González-RosaBiology Department, Morrissey College of Arts and Sciences, Boston College, Chestnut Hill, MA 02467, USA; Cardiovascular Research Center, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA 02129, USA. Electronic address: gonzaaml@bc.edu.

Funding

Identifying new regulators of cardiac fibrosis and inflammation using zebrafishR01HL164749 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Juan Manuel Gonzalez-Rosa · 2022 to 2026
$2.0M
NHLBI NIH HHS R01 HL164749
6 · The paper itself

Abstract

CRISPR-Cas9 has accelerated loss-of-function studies in zebrafish, but creating tissue-specific mutant lines is still labor intensive. While some tissue-specific Cas9 zebrafish lines exist, standardized methods for gene targeting, including guide RNA (gRNA) delivery, are lacking, limiting broader use in the community. To tackle these limitations, we develop a cardiomyocyte-specific Cas9 line, the cardiodeleter, that efficiently generates biallelic mutations in combination with gene-specific gRNAs. We create transposon-based guide shuttles that deliver gRNAs targeting a gene of interest while permanently labeling cells susceptible to becoming mutant. We validate this modular approach by deleting five genes (ect2, tnnt2a, cmlc2, amhc, and erbb2), resulting in the loss of the corresponding protein or phenocopy of established mutants. We provide detailed protocols for generating guide shuttles, facilitating the adoption of these techniques in the zebrafish community. Our approach enables rapid generation of tissue-specific crispants and analysis of mosaic phenotypes, making it a valuable tool for cell-autonomous studies and genetic screening.

Indexed as

CRISPR-Cas SystemsGene EditingMyocytes, CardiacZebrafishAnimalsMutationRNA, Guide, CRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsCP: developmental biologyCP: geneticscrispantsCRISPR-Cas9myocardiumtissue-specific mutantstransgenesis

Identifiers

PMID40132543
PMCPMC12049713

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.